Cover Image

Methods other than Experimental Animals for Screening Antitumor Compounds

Amro Abd Al Fattah Amara


Some scientists avoid the work with experimental animals. For that, it is important to describe alternative methods. In this review, some bioassays were described as an alternative for the experimental animals. The concept of cancer formation was discussed to show why such bioassays are useful for detecting antitumor compounds. The bioassays described in this review are technical, practical and recommended as a preliminary screening of large samples for the existences of antitumor activities. Such bioassays could reduce the pain of the experimental animals.


Plant; Antitumor; Bioassays

Full Text:



Jimmie C, Holland M, Lean O, Cullen M. New Insight and Attitudes. In Cancer book: Prevention Detection Diagnosis Treatment Rehabilitation and Cure“(Eds.Arthur I Holleb M.D.) USA; Doubleday Co.; 1986

Ackerknecht EH. [The concept of cancer in changing times]. Ophthalmologica. 1961, 14:239-246

Baum M, Colletta A. Breast Cancer: A Revolutionary Concept. Breast Cancer. 1995, 2:9-18

Abe T, Horiike S. [Inherited cancer--concept and classification]. Nihon Rinsho. 1995, 53:2627-2633

Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumor progression. Nat Rev Cancer. 2005, 5:744-749

Bernier J, Bourhis J. Introducing the BECT (biologically enhanced cytotoxic treatment). concept in cancer treatment. Ann Oncol. 2005, 16:1722

Bartek J, Lukas J, Bartkova J. DNA damage response as an anticancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle. 2007, 6:2344-2347

Bragado C, Hernandez-Lloreda MJ, Sanchez-Bernardos ML, Urbano S. [Physical self-concept, anxiety, depression, and self-esteem in children with cancer and healthy children without cancer history]. Psicothema. 2008, 20:413-419

Bristow RE. Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen. Gynecol Oncol. 2009, 112:1-3

Hnahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000, 100:57-70

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011, 144:646-674.

Amara AA. Cancer and anticancer: A discussion. Ed., Germany; Amro Amara Schüling Verlag; 2011

Amara AA. Toward healthy genes Ed. Germany; Amro Amara Schüling Verlage; 2012

Balsano C, Alisi A. Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential. Dig Liver Dis. 2007, 39 Suppl 1:S46-51

Butter C, Staines K, Baaten B, Smith L, Davison TF. Route of challenge is critical in determining the clinical outcome of infection with a very virulent oncogenic herpesvirus, Marek's disease virus. Avian Pathol. 2007, 36:93-99

Kedzia W, Gozdzicka-Jozefiak A. [Mechanism of the cancerogenesis in cervix paraepidermal epithelium cells with chronic infection of oncogenic types of human papiloma virus]. Ginekol Pol. 2007, 78:701-708

Maeda N, Yoshikai Y. [New molecular mechanisms of virus-mediated carcinogenesis: oncogenic transformation of cells by retroviral structural protein Envelope]. Uirusu. 2007, 57:159-170

Oishi N, Shilagardi K, Nakamoto Y, Honda M, Kaneko S, et al. Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells. Cancer Sci. 2007, 98:1540-1548

Stenvall H, Wikstrom I, Wilander E High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening. Acta Derm Venereol. 2007, 87:243-245

Catarino R, Pereira D, Breda E, Coelho A, Matos A, et al. Oncogenic virus-associated neoplasia: a role for cyclin D1 genotypes influencing the age of onset of disease? Biochem Biophys Res Commun. 2008, 370:118-122

Cline M, Haskell C, Introduction to Chemotherapy (pp1-27) In “Cancer Chemotherapy Cline” (Eds M.J. Haskell C.M.) 2nd ed. London; Saunders W.B. Company; 1976

Frobisher M, Fundementals of microbiology: an introduction to the microorganisms with special reference to the procaryons. 8 ED. Co. USA; W. B. Saunders; 1968

Huang H, Ng M, Lo K, Lee J. Molecular basis of cancer. HKMJ. 1997, 3:186-194

Lippicott J, Lippicott B. The genus Agrobacterium and plant tumorigenesis. Annu Rev Microbiol. 1975, 29:377-405

Amro AA. The philosophy behind exo/endo/existing antioxidants and our built-in oxidant and antioxidant system. Pharmazie. 2010, 65:711-719

Ogawa Y, Ishikawa K, Mii M Highly tumorigenic Agrobacterium tumefaciens strain from crown gall tumors of chrysanthemum. Arch Microbiol. 2000, 173:311-315

Zhang XY, Li WG, Wu YJ, Tian X. Antioxidative and antitumor activity of derivatives of 4-beta-amino-4'-demethylepipodophyllotoxin and their structure-activity relationship. Pharmazie. 2007, 62:432-438

Caldwell GS, Bentley MG, Olive PJ. The use of a brine shrimp (Artemia salina). bioassay to assess the toxicity of diatom extracts and short chain aldehydes. Toxicon. 2003, 42:301-306

Sakurai H, Fujii Y, Maki Y, Igarashi I, Omata Y, Saito A, Ono K, Suzuki N. n vitro and in vivo studies of the growth inhibitory effect of a newly synthesized peptide, obiopeptide-1, on mice-bearing methylcholanthrene-induced murine tumors. 1991, J Vet Med Sci. 53:823-831.

Shrestha R, Fujimoto S, Okui K A novel anticancer treatment for xenoplanted human gastric cancer using polyamine antimetabolites in a low polyamine. Ditet Jap J Surg. 1992, 22:137-142

Weir D. Acquired immunity (pp 36-103).In “Immunology “ (Eds Weir D.M.) 5th ed. England; Churchill Living Stone; 1983

Xu, Q, Mori, H, Sakamoto, O, Uesugi,Y, Koda, A. Immunological mechanisms of antitumor activity of some kinds of crude drugs on tumor necrosis factor production. Int J Immunopharmacol. 1989, 11:607-613

MarshallGoldberg M. The Immune system’s newest weapons against cancer (pp.1-22). In “Cell Wars”(1st Ed.). Toronto, Canada; Collins Publishers; 1988

Cline M, Haskell C. Classes of chemotherapeutic agent. In “Cancer Chemotherapy” (Eds. Cline M. and Haskell C.) 2nd ed. London; Saunders W.B Company; 1976: 28-83

You J, Kau D, Chen K, Huang H. Combined effects of chuling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer. Am J Chin Med. 1994, 22:19-28

Goeptar A, Groot E, Scheerenes H, Commandeur J, Vermeulen N. Cytotoxicity of mutomycin C and adriamycin in freshely isolated rat hepatocytes: The role of CYP450. Cancer Res. 1994, 54: 2411-2418

Hoffmann G, Littlefield L. Enhancement of the activity of bleomycin by cysteamine in a micronucleus assay in human lymphocytes. Toxicol Lett. 1995, 78:147-151

Moore C. Potentiation of Bleomycin cytotoxicity in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 1994, 38:1615-1619

Currie G, Currie A. Cancer: The Biology of malignant disease 1st edition. London; Edward Arnold Ltd; 1982

Salo M, Kiviranta J, Knuutila V, Kangas L, Vuorela H. Biological activity and enzymatic hydrolysis of retinoates in vitro. Eur J Pharm Sci. 1995, 3:71-76

Mlinaric A, Kreft S, Umek A, Strukelj B. Screening of selected plant extracts for in vitro inhibitory activity on HIV-1 reverse transcriptase (HIV-1 RT). Pharmazie. 2000, 55:75-77

Oleski A, Lindequist U, Mothana RA, Melzig MF. Screening of selected Arabian medicinal plant extracts for inhibitory activity against peptidases. Pharmazie. 2006, 61:359-361

Stano J, Micieta K, Neubert K, Luckner M, Adam H. A simple method for the identification and assay of extracellular plant beta-galactosidase. Pharmazie. 2002, 57:176-177

Suffredini IB, Paciencia ML, Varella AD, Younes RN. In vitro prostate cancer cell growth inhibition by Brazilian plant extracts. Pharmazie. 2006, 61:722-724

Suffredini IB, Paciencia ML, Frana SA, Varella AD, Younes RN. In vitro breast cancer cell lethality of Brazilian plant extracts. Pharmazie. 2007, 62:798-800

Mothana RA, Grunert R, Lindequist U, Bednarski PJ. Study of the anticancer potential of Yemeni plants used in folk medicine. Pharmazie. 2007, 62:305-307

Helton L. Folk medicine and health beliefs: an Appalachian perspective. J Cult Divers. 1996, 3:123-128

Mail P, McKay R, Katz M. Expanding practice horizons: learning from American Indian patients. Patient Educ Couns. 1989, 13:91-102

Dubick A. Historical perspectives on the use of Herbal preparations to promote health. J Natr. 1986, 116:1348-1354

Amara AA, El-masry M, Baghdadi H. Plant crude extracts could be the solution: extracts showing in vivo antitumorigenic activity. Pak J Pharm Sci. 2008, 21:159-171

Sun M, Zeng JJ. A study on the hairy root culture and antitumor alkaloids production of Catharanthus roseus. Zhongguo Zhong Yao Za Zhi. 2005, 30:741-743

Gordaliza M Castro M Garcia-Gravalos M Ruiz P Miguel del Corral J. San Felicano A. Antineoplastic and antiviral activities of podophyllotoxin related lignans. Arch Pharm. 1994, 327:175-179

Wani M, Ronman P, Lindley J, Wall M. Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues. J Med Chem. 1980, 23:554-560

Coker P, Radecke J, Guy C, Camper N. Potato disc tumor induction bioassay: A multiple mode of drug action assay. Phytomedicine. 2003, 10:133-138

Kupchan S, Dessentin A, Blaylock B, Bryan R. Isolation and structure elucidation of allmondin an antileukemic iridoid lactone from Allamanda cathartica. J Org Chem. 1974, 39:2477-2482

Blasko G, Cordell G.. Recent Developments in the chemistry of plant-derived anticancer agents. In “Economic and Medicinal Plant Research”. (Eds. Wager H Hikino H Fransworth N.R.), U K; Academic Press; 1988: 119-191

Lee K, Ibuka K, Huang HC letter D. Antitumor agents XIV: Molephantinin a new potant antitumor sesquiterpene lactone from Elephantopus mollis. J Parm Sci. 1975, 64:1077-1078

Wang H, Gao H, Wang Q, Gao Q, Lin C. Specific anticancer activity of a new bisabolane sesquiterpene against human leukemia cells inducing differentiation in vitro. Pharmazie. 2007, 62:699-704

Lee K, Cowherd C, Wolo M. Antitumor agents XV:Deoxyelephantopin an antitumor principal from Elephantopus carolinianus Willd. J Pharm Sci. 1975, 64:1572-1573

Kupchan S, Hemingway R, Werner D, Karin A, Mcphail A, Sim, G. Vernolepin:a noval elemanolide dilactone tumor inhibitor from Verononia hymenolepis. J Amer chem Soc. 1968, 90:3596-3597

Mark W, Fong S, Tin-WA, Fransworth N. Cytotoxic principles of Parquetine nigrescens (Afzel) Bullock (Asclepiadaceae). J Pharm Sci. 1975, 64:1674-1676

Sakagami H, Kawazoe Y, Oh T, Kitajima K, Inoue Y, Tanuma S, Ichikawa S, Konno K. Stimulation of human peripheral blood polymorphonuclear cell iodination by Lignin-related substances. J Leukoc Biol. 1991, 49:277-282

Loder J, Nearn R. Structure of nonerythrostachaldine a cytotoxic alkaloid from Erythrophleum chlorostachys (leguminosea). Aust J Chem. 1975, 28:651-656

Dutschewsha H, Mallov N. Structure of dehydro thalicarpine a new aporphine benzylisoquinoline alkaloid from Thalictrumminus elatum. Chem Ind. 1966, 770

Kupchan S, Liepa A. Tumor-inhibting thalicarpines. Chem Abst. 83:59135

Fish F, Gray A, Watherman P, Donachie F 1975, Alkaloids and coumarins from North American Zanthoxylum species. LLOYDIA. 1974, 38:268-270

Shvarev I, Tselin A. Antiblastic properties of barberine and its derivatives. Farmkal Toksikol. 35:73-75

Sharma A, Straubinger RM. Novel taxol formulations: Preparation and characterization of taxolcontaining liposomes. Pharmac Res. 1994, 11:889-896

Pantazis P, Kozielski AJ, Mendoza JT, Early JA, Hinz HR, Giovanella BC. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro. Int J Cancer. 1993, 53:863-871

Mikolajczak K Powell R. Smith C. Deoxyharringtonine a new antitumor alkaloid from Cephalotaxus: structure and synthesis studies. Tetrahedron. 1972, 28:1995-2001

van der Schoot SC, Vainchtein LD, Nuijen B, Gore A, Mirejovsky D, Lenaz L, Beijnen JH. Purity profile of the indoloquinone anticancer agent EO-9 and chemical stability of EO-9 freeze dried with 2-hydroxypropyl-beta-cyclodextrin. Pharmazie. 2008, 63:796-805

Schwaller M, Aubard J, Doin G. Kinetic and thermodynamics studies on drug-DNA interactions in the ellipiticine series. Anticancer Drug Des. 1990, 5:77-87

Adlercreutz, H, Carson, M, Mousavi, Y, Palotie, A, Booms, S, Loukovaara, M, Makela, T, Wahala, K, Brunow, G, Hase,T. Lignans and isoflavonoids of dietary origin and hormone1dependent cancer (pp.3481352). In “Food and cancer prevention, chemical and biological aspects” [Eds Waldron,K.W., Johnson,I. T.and Fenwick, G.R.] 3481352., UK; Royal Society of Chemistry Cambridge; 1993

Meyer B, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DC, Melaughlin JL. Brine shrimp: A convenient general bioassay for active plant constituents. J. Planta Medica. 1982, 45:31-34

Alali FQ, Tawaha K, El-Elimat T, Qasaymeh R, Li C, Burgess J, Nakanishi Y Kroll DJ, Wani MC. Oberlies N. Phytochemical studies and cytotoxicity evaluations of Colchicum tunicatum Feinbr and Colchicum hierosolymitanum Feinbr (Colchi- caceae): two native Jordanian meadow saffrons. Nat Prod Res. 2006, 20:558-566

Kazmi SU, Ali SN, Jamal SA, Atta UR-Rahman. New bioactive compounds of plant origin. Pak J Pharm Sci. 1991, 4:113-123

Jayasuriya H, Mcchesney JD, Swanson SM, Pezzuto JM. Antimicrobial and cytotoxic activity of rottlerin-type compounds from Hypericum drummondii. J Nat Prod. 1989, 52:325-331

Venkateswara R, Rao J, Kavitha P, Jakka NM, Sridhar VM, Usman PK. Toxicity of Organophosphates on Morphology and Locomotor Behavior in Brine Shrimp Artemia salina. Arch Environ Contam Toxicol. 2007, 53:227-232

Harwing J, Scott PM. Brine shrimp (Artemia salina L.) larvae as a screening system for fungal toxins. Appl. Microbiol 1971, 21:1011-1016

Robinson AB, Manly KF, Anthony MR, Cachpool JF, Pauling L. Anesthesia of Artemia larvae; Method for quantitative study. Science. 1965, 149:1255-1258

Granada HR, Change PC, Doorenbos VJ, Ciguatera I. Brine shrimp (Artemia saline L.) larval assay for Ciguatera toxins. J Pharm Sci. 1976, 65:1414-1416

Sanchez C, Gupta M, Vásquez M, De Noriega Y, Montenegro G. [Bioassay with brine Artemia to predict antibacterial and pharmacologic activity]. Rev Med Panama. 1993, 18:62-69

Chohan ZH, Mahmood U, Khan KM, Supuran CT. In vitro antibacterial antifungal and cytotoxic properties of sulfonamide-derived Schiff's bases and their metal complexes. J Enzyme Inhib Med Chem. 2005, 20:183-188

El-Masry MH, Mostafa HH, Ibrahim AM, EL-Nagger M. Marine algae that display anti- tumorigenic activity against Agrobacterium tumefaciens. FEMS Microbiol Lett. 1995, 128:151-156

Day R, Criel GR, Walling MA, MacRae TH. Posttranslationally modified tubulins and microtubule organization in hemocytes of the brine shrimp, Artemia franciscana. J Morphol. 2000, 244:153-166

Chalko CJ, Morre DM, Morre DJ. Cell surface NADH oxidase activity of brine shrimp oscillates with a period of 25 min and is entrained by light. Life Sci. 2000, 66:2499-2507

Lee S, Min B, Kho Y. Brine shrimp lethality of the compounds from Phryma leptostachya L. Arch Pharm Res. 2002, 25:652-654

Brix KV, Cardwell RD, Adams WJ. Chronic toxicity of arsenic to the Great Salt Lake brine shrimp, Artemia franciscana. Ecotoxicol Environ Saf. 2003, 54:169-175

Calcott PH, Fatig RO. Avermectin modulation of Gaba binding to membranes of rat, brain shrimp and fungus, Mucor miehei. Antibiotics J. 1984, 7:797-801

Castritsi-Catharios J, Bourdaniotis N, Persoone G. A new simple method with high precision for determining the toxicity of antifouling paints on brine shrimp larvae (Artemia): first results. Chemosphere. 2007, 67:1127-1132

Feng CZ, Zhu XJ, Dai ZM, Liu FQ, Xiang JH, Yang WJ. Identification of a novel DNA methyltransferase 2 from the brine shrimp, Artemia franciscana. Comp Biochem Physiol B Biochem Mol Biol. 2007, 147:191-198

Juma BF, Majinda RR. Constituents of Gardenia volkensii: their brine shrimp lethality and DPPH radical scavenging properties. Nat Prod Res. 2007, 21:121-125

Koutsaftis A, Aoyama I. Toxicity of four antifouling biocides and their mixtures on the brine shrimp Artemia salina. Sci Total Environ. 2007, 387:166-174

Nakamura K, Iwaizumi K, Yamada S. Hemolymph patterns of free amino acids in the brine shrimp Artemia franciscana after three days starvation at different salinities. Comp Biochem Physiol A Mol Integr Physiol. 2007, 147:254-259

Munoz J, Green AJ, Figuerola J, Amat F, Rico C. Characterization of polymorphic microsatellite markers in the brine shrimp Artemia (Branchiopoda, Anostraca). Mol Ecol Resour. 2009, 9:547-550

Bastos ML, Lima MR, Conserva LM, Andrade VS, Rocha EM, Lemos RP. Studies on the antimicrobial activity and brine shrimp toxicity of Zeyheria tuberculosa (Vell.). Bur. (Bignoniaceae). extracts and their main constituents. Ann Clin Microbiol Antimicrob. 2009, 8:16

Moshi MJ, Innocent E, Masimba PJ, Otieno DF, Weisheit A, Mbabazi P. Lyres M. Meachem K. Hamilton A. Urassa I. Antimicrobial and brine shrimp toxicity of some plants used in traditional medicine in Bukoba District, north-western Tanzania. Tanzan J Health Res. 2009, 11:23-28

Munoz J, Gomez A, Green AJ, Figuerola J, Amat F, Rico C. Phylogeography and local endemism of the native Mediterranean brine shrimp Artemia salina (Branchiopoda: Anostraca). Mol Ecol. 2008, 17:3160-3177

Ferrigni N, McLaughlin J. owell RG. Smith CR. Jr. Use of Potato disc and Brine Shrimp bioassays to detect activity and isolate picetannol as the antileukemic principle from the seeds of Euphorbia lagascae. J Nat Prod. 1984, 47:347- 352

McLaughlin J, Roger L. The use of biological assays to evaluate botanicals. J Drug Information. 1998, 32:513-524

Jackson DV, Rosenbaum DL, Carlisle LJ, Long TR, Wells HB, Spurr CL. Glutamic acid modification of vincristine toxicity. Cancer Biochem Biophys. 1984, 7:245-252

Wall M, Wani M. Antineoplastic agents from plants. Ann Rev Pharmacol Toxicol. 1977, 17:117:-132

Perdue R. KB Cell culture. I. Role in discovery of antitumor agents from higher plants. J Nat Prod. 1982, 45:418-426

DeCleene M, DeLay J. The host range of crown gall. Bot Rev. 1976, 42:389-466

White P, Braun A. A cancerous neoplasm of plants: autonomous bacteria-free crown gall tissue. Cancer Res. 1942, 2:597-617

Tempé J, Petit A. Opine Utilization by Agrobacterium. New York; Academic; 1982

Hiei Y, Komari T, Kubo T. Transformation of rice mediated by Agrobacterium tumefaciens. Plant Mol Biol. 1997, 35:205-218

Chen Y, Lu L, Deng W, Yang X, McAvoy R, Zhao D, Pei Y, Luo K, Duan H, Smith W, Thammina C, Zheng X, Ellis D, Li Y. In vitro regeneration and Agrobacterium-mediated genetic transformation of Euonymus alatus. Plant Cell Rep. 2006, 25:1043-1051

Bundock P, den Dulk-Ras A, Beijersbergen A, Hooykaas P. Trans-kingdom T-DNA transfer from Agrobacterium tumefaciens to Saccharomyces cerevisiae. EMBO J. 1995, 14:3206-3214

Abuodeh RO, Orbach MJ, Mandel MA, Das A, Galgiani JN. Genetic transformation of Coccidioides immitis facilitated by Agrobacterium tumefaciens. J Infect Dis. 2000, 181:2106-2110

Kunik T, Tzfira T, Kapulnik Y, Gafni Y, Dingwall C, Citovsky V. Genetic transformation of HeLa cells by Agrobacterium. Proc Natl Acad Sci USA. 2001, 98:1871-1876

Anand V, Herberleim G. Crown gall tumorigenesis in potato tumor tissue. Ann J Bot. 1977, 64:153-158

Braun AC. The relevance of plant tumor systems to an understanding of the basic cellular mechanisms underlying tumorigenesis. Prog Exp Tumor Res. 1972, 15:165-187

Favus S, Gonzalez O, Bowman P, Galsky A. Inhibition of crown gall tumor formation on potato disc by cyclic-AMP and prostaglandins E1 and E2. Plant Cell Physiol. 1977, 18:469-472

Galsky AG, Wilsey JP. Crown Gall Tumor Disc Bioassay: A possible aid in the detection of compounds with antitumor activity. Plant Physiol. 1980, 65:184-185

Galsky AG, Kozimor R, Piotrowski D, Powell RG. The crown gall potato disk bioassay as a primary screen for compounds with antitumor activity. J Natl Cancer Inst. 1981, 67:689-692

Galsky AG, Scheppler JA, Cranford MS. Crown Gall Tumors Possess Tumor-Specific Antigenic Sites on Their Cell Walls. Plant Physiol. 1981, 67:1195-1197

Ferrigni NR, Putnam JE, Anderson B, Jacobson LB, Nichals DE, Moore DS, McLaughin JL. Powell R, Smith CR. Jr. Modification and evaluation of the Potato disc assay and antitumor screening of Euphorbiaceae seeds. J Nat Prod. 1982, 45:679-686

Das B, Kundu J, Bachar SC, Uddin MA, Kundu JK. Antitumor and antibacterial activity of ethylacetate extract of Ludwigia hyssopifolia Linn and its active principle piperine. Pak J Pharm Sci. 2007, 20:128-131

Holder IA, Boyce ST. Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture. Burns. 1994, 20:426-429

Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N. Mitov I. Kraster Z. Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar well diffusion, agar dilution and disc diffusion methods. J Med Microbiol. 2005, 54:481-483

Athanassiadis B, Abbott PV, George N, Walsh LJ. An in vitro study of the antimicrobial activity of some endodontic medicaments and their bases using an agar well diffusion assay. Aust Dent J. 2009, 54:141-146

Tagg J, Mcgiven A. Assay system for bacteriocins. Appl Microbiol. 1971, 21:943-944

Stainer R, Ingraham J, Wheelis M, Painter P. Microbial growth. In “Microbial World” (ed. Simon and Schuster), New Jersey, USA; Englewood Cliffs; 1986

Tolonen A, Uusitalo J. Fast screening method for the analysis of total flavonoid content in plants and foodstuffs by high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry with polarity switching. Rapid Commun Mass Spectrom. 2004, 18:3113-3122

Orhan I, Kartal M, Tosun F, Sener B. Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential. Z Naturforsch C. 2007, 62:829-832

Jin Y, Xiao YS, Zhang FF, Xue XY, Xu Q, Liag XM. Systematic screening and characterization of flavonoid glycosides in Carthamus tinctorius L. by liquid chromatography/UV diode-array detection/electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal. 2008, 46:418-430

Li J, Li QW, Gao DW, Han ZS, Li K. Antitumor effects of total alkaloids isolated from Solanum nigrum in vitro and in vivo. Pharmazie. 2008, 63:534-538

Awney H, Amara AA, El-Masry M, Baghdadi H. Effect of 12 plant extracts on hepatic microsomal benzo[a] pyrene hydroxylation and hydrogen peroxide production on mice treated with lindane. Env Nutr Interactions. 1997, 3:129-142

Rayan D Lu A. Levin W. Preparation of rat hepatic microsomes. Methods in Enzymology. 1978, 752 118-122

Lowry OH, Rosebrough N, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951, 193:265-269

Hildebrandt A, Root I, Tjoe M, Heinemeyer G. Hydrogen peroxide in hepatic microsomes. Methods Enzymology. 1978, 52:342-350

Peng HY, Zhang YH, Han Y, Wang M. [Studies on the anticancer effects of total alkaloid from Viscum coloratum]. Zhongguo Zhong Yao Za Zhi. 2005, 30:381-382, 387

Shinkre BA, Raisch KP, Fan L, Velu SE. Analogs of the marine alkaloid makaluvamines: synthesis, topoisomerase II inhibition, and anticancer activity. Bioorg Med Chem Lett. 2007, 17:2890-2893

Bhattacharyya SS, Mandal SK, Biswas R, Paul S, Pathak S, Bouiedaini N. Beion P. Khuda-Bukhsh AR. In vitro studies demonstrate anticancer activity of an alkaloid of the plant Gelsemium sempervirens. Exp Biol Med Maywood. 2008, 233:1591-1601

Rabbani-Chadegani A, Chamani E, Hajihassan Z. The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution. Eur J Pharmacol. 2009, 613:34-38

136. Harborne J. Phytochemical Methods "A guide to modern techniques of plant analysis (second edition) 1-31 New York, USA; Chapman and Hall; 1980

137. Cairnes DA, Ekundayo O, Kingston DG. Plant anticancer agents. X. Lignans from Juniperus phoenicea. J Nat Prod. 1980, 43:495-497

Oblapenko NG, Loknitskaia NN, Presnova Zh F, Chernov VA, Fonshtein LM. [Study of promutagen biotransformation in the Ames test. IV. The effect of transplanted tumors on the biotransformation of various antineoplastic agents]. Genetika. 1986, 22:2265-2271

Schimmer O, Kruger A, Paulini H, Haefele F. An evaluation of 55 commercial plant extracts in the Ames mutagenicity test. Pharmazie. 1994, 49:448-451

Duhan OM, Baryliak IR, Nester TI, Dvornyk AS, Kunakh VA. [The antimutagenic activity of biomass extracts from the cultured cells of medicinal plants in the Ames test]. Tsitol Genet. 1999, 33:19-25

Hadi SM, Bhat SH, Azmi AS, Hanif S, Shamim U, Ullah MF. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin Cancer Biol. 2007, 17:370-376

Ames, B, Whitfield H, Frameshift Mutagenesis in Salmonella. Cold Spring Harbor Symp. Quant Biol. 1966, 31: 221-225

Ames B. The Detection of Chemical mutagens with enteric bacteria. pp. 267-282. Chemical mutagens: Principles and methods for their detection. Vol. 1. Edited by A. H laender. Plenum Press New York N.Y. - 1972 A Bacterial System for Detecting Mutagens and Carcinogens. pp. 57-66. In Mutagenic Effects of Environmental Contaminants Edited by E. Sutton and M. Harris. N.Y, USA; Academic Press New York: 1971

Ames BN, Sims P, Grover P. Epoxides of Polycyclic hydrocarbons are frameshift mutagens. Science. 1972, 176:47-49

Ames BN, Durston WE, Yamasaki E, Lee FD. 1973, Carcinogens are Mutagens: A Simple Test System Combining Liver Homogenates for Activation and Bacteria for Detection. Proc Natl Acad Sci USA. 70:2281-2285

Vogel H, Bonner D 1956, Acetylonithinase of Escherichia cell: partial purification and some properties. J Biol Chem. 218:97-106


  • There are currently no refbacks.

AJCS(ISSN 2572-5750)Copyright © 2012-2021. All rights reserved. Published by Ivy Union Publishing, 3204 Valley Rush Dr, Apex, North Carolina 27502, United States